Actively Recruiting
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities in Black Youth Living in the Deep South
Led by Tulane University · Updated on 2026-05-05
2322
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
T
Tulane University
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a community-based screening intervention aimed at reducing disparities in chlamydia infections among Black youth aged 15 to 26 years living in the Deep South. The study focuses on testing for four sexually transmitted infections (STIs): chlamydia, gonorrhea, syphilis, and HIV, with a special emphasis on measuring the impact on chlamydia rates in women. Participants will be tested for chlamydia, gonorrhea, syphilis, and HIV at community venues at no cost. Those who test positive for chlamydia or gonorrhea, along with their sexual partners, will be offered expedited treatment options, also at no cost, through participating pharmacies. Additionally, individuals who test positive are encouraged to be rescreened three months after treatment to monitor infection status. During the study, which can last up to 60 months, participants will undergo STI testing and counseling. Researchers will track infection rates for chlamydia and gonorrhea in women over time. The study includes offering counseling and treatment options for positive cases, and participants may be rescreened after treatment. The aim is to assess whether this approach reduces chlamydia rates in the target community while providing ongoing support and monitoring throughout the study period.
CONDITIONS
Brief Title
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Identifies as African American or Black
- 15-26 years of age
- Lives or spends most of their time in Orleans Parish
- Had vaginal sex at least once
You will not qualify if you...
- Unwilling or unable to provide informed consent
- Unable to speak or understand English
- Previously enrolled in the study
- Known to be pregnant
- Known HIV positive status
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) at community based venues for testing
Duration - Up to 60 months
Participants who test positive and their sexual partners are offered expedited treatment and asked to be rescreened for chlamydia and gonorrhea at 3 months post treatment.
Initial treatment visit and rescreening visit at 3 months post treatment; additional assessments may occur depending on participant status
Trial Site Locations
Total: 1 location
1
Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine
New Orleans, Louisiana, United States, 70112
Actively Recruiting
Research Team
P
Patricia Kissinger, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here